Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
Open accessThe DOI matches its Crossref record; 297 of the 302 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
HEPATITIS A IS A VACCINE-PREVENTABLE, COMMUNICABLE DISEASE OF THE LIVER CAUSED BY THE HEPATITIS A VIRUS (HAV). THE INFECTION IS TRANSMITTED VIA THE FECAL-ORAL ROUTE, USUALLY FROM DIRECT PERSON-TO-PERSON CONTACT OR CONSUMPTION OF CONTAMINATED FOOD OR WATER. HEPATITIS A IS AN ACUTE, SELF-LIMITED DISEASE THAT DOES NOT RESULT IN CHRONIC INFECTION. HAV ANTIBODIES (IMMUNOGLOBULIN G [IGG] ANTI-HAV) PRODUCED IN RESPONSE TO HAV INFECTION PERSIST FOR LIFE AND PROTECT AGAINST REINFECTION; IGG ANTI-HAV PRODUCED AFTER VACCINATION CONFER LONG-TERM IMMUNITY. THIS REPORT SUPPLANTS AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMENDATIONS FROM THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) REGARDING THE PREVENTION OF HAV INFECTION IN THE UNITED STATES. ACIP RECOMMENDS ROUTINE VACCINATION OF CHILDREN AGED 12-23 MONTHS AND CATCH-UP VACCINATION FOR CHILDREN AND ADOLESCENTS AGED 2-18 YEARS WHO HAVE NOT PREVIOUSLY RECEIVED HEPATITIS A (HEPA) VACCINE AT ANY AGE. ACIP RECOMMENDS HEPA VACCINATION FOR ADULTS AT RISK FOR HAV INFECTION OR SEVERE DISEASE FROM HAV INFECTION AND FOR ADULTS REQUESTING PROTECTION AGAINST HAV WITHOUT ACKNOWLEDGMENT OF A RISK FACTOR. THESE RECOMMENDATIONS ALSO PROVIDE GUIDANCE FOR VACCINATION BEFORE TRAVEL, FOR POSTEXPOSURE PROPHYLAXIS, IN SETTINGS PROVIDING SERVICES TO ADULTS, AND DURING OUTBREAKS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By 1 month after the first dose, 94%–100% of adults have protective antibody levels, and after a second dose, 100% achieve protective levels (1297,1300,1301).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1297]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Antibody produced in response to HAV infection persists for life and confers protection against reinfection (1297).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1297]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
(1999) · PsycEXTRA Dataset · doi:10.1037/e547812006-001 · Cited by 1,131
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit816 · Cited by 1,037
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
Self-citationShefer, A. M., & Atkinson, W. W. (2011) · Cited by 665
ICTV Virus Taxonomy Profile: Picornaviridae
Zell, R., Delwart, E., Gorbalenya, A. E., Hovi, T., King, A. M. Q., Knowles, N. J., Lindberg, A. M., Pallansch, M. A., Palmenberg, A. C., Reuter, G., et al. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000911 · Cited by 631
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & DeStefano, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 608
McLean, H. Q., Fiebelkorn, A. P., Temte, J. L., & Wallace, G. S. (2013) · PubMed · Cited by 607
Research works printed but not linked: 23
- Favero MSBW. Disinfection and sterilization. In: Zuckerman AJ TH, ed. Viral hepatitis, scientific basis and clinical management. New York: Churchill Livingstone; 1993. pp. 565–75.
- Nelson N. Hepatitis A. CDC yellow book 2020. New York, NY: Oxford University Press; 2020.
- Plunkett, 2019, Vaccine X
- Knopf-Amelung S. Incarceration and homelessness: a revolving door of risk. In Focus: A Quarterly Research Review of the National Health Care for the Homeless Council 2013;2:5. https://nhchc.org/wp-content/uploads/2019/08/infocus_incarceration_nov2013.pdf
- Safran, 2010, Hepatitis A/B prevention at Washington State Penitentiary., J Investig Med, 58, 242
- CDC, 2007, FDA approval of an alternate dosing schedule for a combined hepatitis A and B vaccine (Twinrix®)., MMWR Morb Mortal Wkly Rep, 56, 1057
- Nelson, 2018, Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel., MMWR Morb Mortal Wkly Rep, 67, 1216, 10.15585/mmwr.mm6743a5 · DOI
- Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med [Review]. 2018;8:01. · DOI · Paper page
- Mohd Hanafiah, 2011, Challenges to mapping the health risk of hepatitis A virus infection., Int J Health Geogr, 10, 57, 10.1186/1476-072x-10-57 · DOI
- Nelson, 2017, Updated dosing instructions for immune globulin (human) GamaSTAN S/D for hepatitis A virus prophylaxis., MMWR Morb Mortal Wkly Rep, 66, 959, 10.15585/mmwr.mm6636a5 · DOI
- Nelson, 2018, Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel., MMWR Morb Mortal Wkly Rep, 67, 1216, 10.15585/mmwr.mm6743a5 · DOI
- Link-Gelles, 2018, Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use., Vaccine, 36, 2745, 10.1016/j.vaccine.2018.04.015 · DOI
- Fiore, 2004, Hepatitis A transmitted by food., Clin Infect Dis, 38, 705, 10.1086/381671 · DOI · Paper page
- Staes, 2000, Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak., Pediatrics, 106, E54, 10.1542/peds.106.4.e54 · DOI
- Koff, 1992, Clinical manifestations and diagnosis of hepatitis A virus infection., Vaccine, 10, S15, 10.1016/0264-410x(92)90533-p · DOI · Paper page
- Sharapov, 2016, Hepatitis A infections among food handlers in the United States, 1993–2011., Public Health Rep, 131, 26, 10.1177/003335491613100107 · DOI
- Morey, 2017, The financial burden of public health responses to hepatitis A cases among food handlers, 2012–2014., Public Health Rep, 132, 443, 10.1177/0033354917710947 · DOI
- Ridpath, 2017, Hepatitis A cases among food handlers: a local health department response—New York City, 2013., J Public Health Manag Pract, 23, 571, 10.1097/phh.0000000000000526 · DOI
- Hofmeister, 2020, Notes from the field: assessing the role of food handlers in hepatitis A virus transmission—multiple states, 2016–2019., MMWR Morb Mortal Wkly Rep, 69, 636, 10.15585/mmwr.mm6920a4 · DOI
- Rosenblum, 1991, Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants., J Infect Dis, 164, 476, 10.1093/infdis/164.3.476 · DOI · Paper page
- Noble, 1984, Posttransfusion hepatitis A in a neonatal intensive care unit., JAMA, 252, 2711, 10.1001/jama.1984.03350190013011 · DOI
- Foster, 2017, Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation., Emerg Infect Dis, 23, 590, 10.3201/eid2304.161532 · DOI
- Klein, 1984, Nosocomial hepatitis A. A multinursery outbreak in Wisconsin., JAMA, 252, 2716, 10.1001/jama.1984.03350190018012 · DOI
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Surveillance of Vaccination Coverage Among Adult Populations —United States, 2018
Lu, P.-J., Hung, M.-C., Srivastav, A., Grohskopf, L. A., Kobayashi, M., Harris, A. M., Dooling, K. L., Markowitz, L. E., Rodriguez-Lainz, A., & Williams, W. W. (2021) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7003a1 · Cited by 346
Self-citationHepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
Migueres, M., Lhomme, S., & Izopet, J. (2021) · Viruses · doi:10.3390/v13101900 · Cited by 176
“Vaccination has been recommended for MSM and people who use substances for several decades, and people who face homelessness have recently been added to the Advisory Committee on Immunization Practices (ACIP) list [24].”
BackgroundInfluentialZeng, D.-Y., Li, J.-M., Lin, S., Dong, X., You, J., Xing, Q.-Q., Ren, Y., Chen, W.-M., Cai, Y.-Y., Fang, K., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.035 · Cited by 182
EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy
Williamson, C., Nana, M., Poon, L. C., Kupčinskas, L., Painter, R. C., Taliani, G., Heneghan, M. A., Marschall, H., & Beuers, U. H. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.006 · Cited by 176
Metadata
- Authors
- Nelson, N. P., Weng, M. K., Hofmeister, M. G., Moore, K. L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J. R., Schillie, S., & Harris, A. M.
- Affiliations
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Vanderbilt University (US)
- Centers for Disease Control and Prevention (US)
- University of Arkansas for Medical Sciences (US)
- Corresponding author
- Nelson, Noele P.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2020-07-03
- Volume
- 69
- Issue
- 5
- Pages
- 1-38
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8631741
- OpenAlex
- W3038438460
- Cited by
- 264
- References
- 302
- Citations by year
- 2026: 35 · 2025: 43 · 2024: 45 · 2023: 52 · 2022: 41 · 2021: 42 · 2020: 5
- FWCI
- 20.57
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- National Center for Immunization and Respiratory Diseases
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatitis A virus, hepatitis A vaccination, vaccine recommendations, routine childhood immunization, catch-up vaccination, high-risk adults, pre-travel vaccination, post-exposure prophylaxis, anti-HAV IgG, fecal-oral transmission
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Hepatitis A, Humans, Immunization, Infant, United States, Practice Guidelines as Topic, Hepatitis A Vaccines, Advisory Committees
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. https://app.cochat.ai/papers/10.15585/mmwr.rr6905a1
- The paper
- Nelson, N. P., Weng, M. K., Hofmeister, M. G., Moore, K. L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J. R., Schillie, S., & Harris, A. M. (2020). Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR. Recommendations and Reports. https://doi.org/10.15585/mmwr.rr6905a1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.